MRI Interventions’ ClearPoint® Neuro Navigation System to be Exhibited at Pediatric Neurosurgical Conference
ClearPoint Neuro Navigation system offers minimally invasive neurosurgical navigation option for pediatric patients suffering from movement disorders
IRVINE, Calif., Dec. 05, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Navigation System will be exhibited at the 45th Annual Meeting of the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Pediatric Neurological Surgery, taking place December 5 - 8, 2016, in Orlando, Florida.
“In pediatric brain surgery, precision, real-time, image guided navigation and device placement are especially important. Pediatric patients and their families benefit from the reduced discomfort and improved patient experience when the ClearPoint System is utilized for navigation. For these reasons, we continue to see strong adoption of the ClearPoint System among leading children’s hospitals," stated Wendelin Maners, Vice President of Marketing for MRI Interventions. “These centers are utilizing the ClearPoint System for treating fragile patients with dystonia, epilepsy or brain tumors. We are proud to work with innovative pediatric neurosurgeons and children’s hospitals to offer asleep, frameless, minimally invasive surgical options for their young patients, and we look forward to being part of their annual meeting.”
AANS/CNS Section attendees are invited to visit the MRI Interventions booth (#300) to learn about the ClearPoint Neuro Navigation System. ClearPoint goes beyond planning, enabling surgeons to perform a wide range of minimally-invasive neurosurgical procedures under real-time MRI visualization.
About MRI Interventions, Inc.
Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
Statements herein concerning MRI Interventions, Inc. (the “Company”) plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company's actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: the Company’s ability to obtain additional financing; estimates regarding the sufficiency of the Company’s cash resources; future revenues from sales of the Company’s ClearPoint system products; and the Company’s ability to market, commercialize and achieve broader market acceptance for the Company’s ClearPoint system products. More detailed information on these and additional factors that could affect the Company’s actual results are described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2016, both of which have been filed with the Securities and Exchange Commission.
Contact: Wendelin Maners, VP, Marketing MRI Interventions, Inc. 949-900-6833